Update: 28.02.2023
Last week: 7 week 2023 (13.02.2023 - 19.02.2023)
Last full month: January 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 107 136 | 7.5% | 2.7% | -0.1 | 29 129 830 | 6.3% | 3.4% | -0.1 | 9.8% |
| MoM | 520 912 | -40.9% | 2.8% | -0.3 | 140 500 936 | -33.7% | 3.5% | 0.1 | -34.9% |
| YTD | 779 836 | -69.6% | 2.8% | -3.3 | 211 735 602 | -56.7% | 3.5% | -2.4 | -33.7% |
| MAT | 8 060 712 | -45.1% | 4.2% | -2.4 | 1 743 243 106 | -32.5% | 4.2% | -1.8 | -14.4% |
| DEXALGIN | |||||||||
| WoW | 15 524 | 7.5% | 0.3% | 0 | 8 567 793 | 7.4% | 1.1% | 0 | 6.8% |
| MoM | 86 116 | -0.8% | 0.4% | 0.1 | 45 595 997 | 7.9% | 1.4% | 0.3 | -18.7% |
| YTD | 124 197 | -59.8% | 0.4% | -0.4 | 66 596 602 | -44.7% | 1.3% | -0.8 | -20.8% |
| MAT | 1 400 741 | -26.6% | 0.6% | -0.2 | 632 916 364 | -13.4% | 1.6% | -0.4 | -6.2% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 52 904 | 7.5% | 37.6% | -1 | 33 474 419 | 6.6% | 47.0% | -1.7 | 10.2% |
| MoM | 227 468 | -5.8% | 39.3% | -1.6 | 147 485 006 | 4.4% | 50.3% | 1.4 | -1.9% |
| YTD | 358 526 | -53.4% | 38.9% | -22 | 230 967 783 | -36.8% | 49.4% | -18.1 | -27.1% |
| MAT | 3 872 964 | -27.2% | 50.1% | -14.8 | 2 073 868 294 | -16.1% | 56.4% | -13.4 | -5.7% |
| ESPUMISAN BABY | |||||||||
| WoW | 20 762 | 5.3% | 28.8% | -1.3 | 16 273 516 | 4.9% | 46.1% | -1.6 | 9.8% |
| MoM | 89 583 | -11.4% | 29.6% | -1.8 | 69 808 712 | -2.9% | 46.7% | -0.1 | -5.9% |
| YTD | 141 789 | -38.4% | 29.6% | -9.5 | 110 879 609 | -17.6% | 46.9% | -6.6 | -18.6% |
| MAT | 1 337 925 | -18.4% | 35.7% | -5.2 | 881 943 689 | -8.3% | 49.4% | -6.1 | -6.6% |
| FASTUM | |||||||||
| WoW | 13 866 | 7.4% | 0.8% | 0 | 8 419 326 | 7.0% | 2.2% | 0 | 5.8% |
| MoM | 68 305 | 1.6% | 0.9% | 0.1 | 41 973 451 | 9.7% | 2.6% | 0.4 | -9.0% |
| YTD | 102 557 | -47.9% | 0.9% | -0.6 | 62 799 009 | -31.7% | 2.5% | -0.7 | -15.6% |
| MAT | 946 305 | -31.0% | 1.0% | -0.4 | 517 156 073 | -19.0% | 2.4% | -0.7 | -2.7% |
| IODOMARIN | |||||||||
| WoW | 69 317 | 7.2% | 22.4% | 0.1 | 13 012 652 | 7.3% | 9.0% | 0 | 6.6% |
| MoM | 257 852 | -11.8% | 20.9% | -1 | 47 712 069 | -11.1% | 8.0% | -0.6 | -7.4% |
| YTD | 430 516 | -17.7% | 21.5% | -0.7 | 80 068 730 | -17.2% | 8.4% | -1.4 | -15.0% |
| MAT | 3 200 629 | -3.1% | 20.4% | -0.7 | 623 397 294 | 1.3% | 8.9% | -0.7 | 0.3% |
| LIOTON | |||||||||
| WoW | 17 821 | 15.0% | 1.9% | 0.1 | 22 643 350 | 16.5% | 4.9% | 0.2 | 8.4% |
| MoM | 59 882 | -11.1% | 1.6% | 0 | 74 104 261 | -7.1% | 4.1% | -0.1 | -8.3% |
| YTD | 104 197 | -44.9% | 1.7% | -0.8 | 130 085 403 | -21.7% | 4.4% | -0.8 | -20.0% |
| MAT | 1 166 835 | -30.9% | 2.1% | -0.6 | 1 271 319 946 | -10.4% | 4.5% | -1.1 | -9.9% |
| MEZYM | |||||||||
| WoW | 206 872 | 9.3% | 19.4% | 0.3 | 32 497 539 | 8.0% | 12.9% | 0 | 7.8% |
| MoM | 1 004 480 | -4.4% | 19.6% | 0.9 | 155 827 241 | -0.0% | 13.4% | 0.7 | -9.0% |
| YTD | 1 499 055 | -54.6% | 19.4% | -10.9 | 234 367 493 | -50.3% | 13.2% | -9.4 | -29.0% |
| MAT | 15 546 115 | -27.1% | 23.9% | -5.7 | 2 406 635 666 | -19.8% | 16.8% | -5.2 | -9.7% |
| MIG 400 | |||||||||
| WoW | 100 056 | 9.1% | 2.1% | 0 | 11 868 453 | 5.4% | 1.6% | 0 | 6.8% |
| MoM | 492 476 | -23.1% | 2.3% | -0.1 | 62 993 861 | -19.9% | 1.9% | -0.1 | -18.7% |
| YTD | 733 326 | -45.6% | 2.2% | -1 | 92 004 984 | -40.6% | 1.8% | -0.9 | -20.8% |
| MAT | 7 782 599 | -24.4% | 3.1% | -0.7 | 931 345 141 | -20.0% | 2.3% | -0.8 | -6.2% |
| PROSTAMOL | |||||||||
| WoW | 22 237 | 18.6% | 13.3% | 0.9 | 33 888 972 | 18.2% | 15.2% | 1.1 | 10.6% |
| MoM | 92 218 | -10.3% | 13.8% | 0.4 | 138 248 618 | -3.9% | 15.6% | 1.2 | -12.6% |
| YTD | 144 179 | -51.7% | 13.4% | -9.4 | 217 715 317 | -44.4% | 15.2% | -8.8 | -18.0% |
| MAT | 1 392 073 | -34.0% | 16.8% | -7.5 | 1 991 303 167 | -25.9% | 18.1% | -8.1 | -4.6% |
| RESPERO MYRTOL | |||||||||
| WoW | 25 106 | 12.8% | 7.1% | 0.3 | 14 621 783 | 12.3% | 8.5% | 0.3 | 8.2% |
| MoM | 103 687 | -36.9% | 7.3% | -1 | 58 772 735 | -31.3% | 8.4% | -0.6 | -28.3% |
| YTD | 163 643 | -42.8% | 7.2% | -3.1 | 93 919 833 | -25.4% | 8.4% | -1.6 | -17.8% |
| MAT | 1 179 229 | 17.5% | 7.8% | 1.3 | 591 497 622 | 29.6% | 8.2% | 1.5 | -1.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 779 836 | -69.6% | 2.8% | -3.3 | 211 735 602 | -56.7% | 3.5% | -2.4 | -33.7% |
| DEXALGIN | 124 197 | -59.8% | 0.4% | -0.4 | 66 596 602 | -44.7% | 1.3% | -0.8 | -20.8% |
| ESPUMISAN (ADULTS) | 358 526 | -53.4% | 38.9% | -22 | 230 967 783 | -36.8% | 49.4% | -18.1 | -27.1% |
| ESPUMISAN BABY | 141 789 | -38.4% | 29.6% | -9.5 | 110 879 609 | -17.6% | 46.9% | -6.6 | -18.6% |
| FASTUM | 102 557 | -47.9% | 0.9% | -0.6 | 62 799 009 | -31.7% | 2.5% | -0.7 | -15.6% |
| IODOMARIN | 430 516 | -17.7% | 21.5% | -0.7 | 80 068 730 | -17.2% | 8.4% | -1.4 | -15.0% |
| LIOTON | 104 197 | -44.9% | 1.7% | -0.8 | 130 085 403 | -21.7% | 4.4% | -0.8 | -20.0% |
| MEZYM | 1 499 055 | -54.6% | 19.4% | -10.9 | 234 367 493 | -50.3% | 13.2% | -9.4 | -29.0% |
| MIG 400 | 733 326 | -45.6% | 2.2% | -1 | 92 004 984 | -40.6% | 1.8% | -0.9 | -20.8% |
| PROSTAMOL | 144 179 | -51.7% | 13.4% | -9.4 | 217 715 317 | -44.4% | 15.2% | -8.8 | -18.0% |
| RESPERO MYRTOL | 163 643 | -42.8% | 7.2% | -3.1 | 93 919 833 | -25.4% | 8.4% | -1.6 | -17.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 8 060 712 | -45.1% | 4.2% | -2.4 | 1 743 243 106 | -32.5% | 4.2% | -1.8 | -14.4% |
| DEXALGIN | 1 400 741 | -26.6% | 0.6% | -0.2 | 632 916 364 | -13.4% | 1.6% | -0.4 | -6.2% |
| ESPUMISAN (ADULTS) | 3 872 964 | -27.2% | 50.1% | -14.8 | 2 073 868 294 | -16.1% | 56.4% | -13.4 | -5.7% |
| ESPUMISAN BABY | 1 337 925 | -18.4% | 35.7% | -5.2 | 881 943 689 | -8.3% | 49.4% | -6.1 | -6.6% |
| FASTUM | 946 305 | -31.0% | 1.0% | -0.4 | 517 156 073 | -19.0% | 2.4% | -0.7 | -2.7% |
| IODOMARIN | 3 200 629 | -3.1% | 20.4% | -0.7 | 623 397 294 | 1.3% | 8.9% | -0.7 | 0.3% |
| LIOTON | 1 166 835 | -30.9% | 2.1% | -0.6 | 1 271 319 946 | -10.4% | 4.5% | -1.1 | -9.9% |
| MEZYM | 15 546 115 | -27.1% | 23.9% | -5.7 | 2 406 635 666 | -19.8% | 16.8% | -5.2 | -9.7% |
| MIG 400 | 7 782 599 | -24.4% | 3.1% | -0.7 | 931 345 141 | -20.0% | 2.3% | -0.8 | -6.2% |
| PROSTAMOL | 1 392 073 | -34.0% | 16.8% | -7.5 | 1 991 303 167 | -25.9% | 18.1% | -8.1 | -4.6% |
| RESPERO MYRTOL | 1 179 229 | 17.5% | 7.8% | 1.3 | 591 497 622 | 29.6% | 8.2% | 1.5 | -1.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 107 136 | 7.5% | 2.7% | -0.1 | 29 129 830 | 6.3% | 3.4% | -0.1 | 9.8% |
| DEXALGIN | 15 524 | 7.5% | 0.3% | 0 | 8 567 793 | 7.4% | 1.1% | 0 | 6.8% |
| ESPUMISAN (ADULTS) | 52 904 | 7.5% | 37.6% | -1 | 33 474 419 | 6.6% | 47.0% | -1.7 | 10.2% |
| ESPUMISAN BABY | 20 762 | 5.3% | 28.8% | -1.3 | 16 273 516 | 4.9% | 46.1% | -1.6 | 9.8% |
| FASTUM | 13 866 | 7.4% | 0.8% | 0 | 8 419 326 | 7.0% | 2.2% | 0 | 5.8% |
| IODOMARIN | 69 317 | 7.2% | 22.4% | 0.1 | 13 012 652 | 7.3% | 9.0% | 0 | 6.6% |
| LIOTON | 17 821 | 15.0% | 1.9% | 0.1 | 22 643 350 | 16.5% | 4.9% | 0.2 | 8.4% |
| MEZYM | 206 872 | 9.3% | 19.4% | 0.3 | 32 497 539 | 8.0% | 12.9% | 0 | 7.8% |
| MIG 400 | 100 056 | 9.1% | 2.1% | 0 | 11 868 453 | 5.4% | 1.6% | 0 | 6.8% |
| PROSTAMOL | 22 237 | 18.6% | 13.3% | 0.9 | 33 888 972 | 18.2% | 15.2% | 1.1 | 10.6% |
| RESPERO MYRTOL | 25 106 | 12.8% | 7.1% | 0.3 | 14 621 783 | 12.3% | 8.5% | 0.3 | 8.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 520 912 | -40.9% | 2.8% | -0.3 | 140 500 936 | -33.7% | 3.5% | 0.1 | -34.9% |
| DEXALGIN | 86 116 | -0.8% | 0.4% | 0.1 | 45 595 997 | 7.9% | 1.4% | 0.3 | -18.7% |
| ESPUMISAN (ADULTS) | 227 468 | -5.8% | 39.3% | -1.6 | 147 485 006 | 4.4% | 50.3% | 1.4 | -1.9% |
| ESPUMISAN BABY | 89 583 | -11.4% | 29.6% | -1.8 | 69 808 712 | -2.9% | 46.7% | -0.1 | -5.9% |
| FASTUM | 68 305 | 1.6% | 0.9% | 0.1 | 41 973 451 | 9.7% | 2.6% | 0.4 | -9.0% |
| IODOMARIN | 257 852 | -11.8% | 20.9% | -1 | 47 712 069 | -11.1% | 8.0% | -0.6 | -7.4% |
| LIOTON | 59 882 | -11.1% | 1.6% | 0 | 74 104 261 | -7.1% | 4.1% | -0.1 | -8.3% |
| MEZYM | 1 004 480 | -4.4% | 19.6% | 0.9 | 155 827 241 | -0.0% | 13.4% | 0.7 | -9.0% |
| MIG 400 | 492 476 | -23.1% | 2.3% | -0.1 | 62 993 861 | -19.9% | 1.9% | -0.1 | -18.7% |
| PROSTAMOL | 92 218 | -10.3% | 13.8% | 0.4 | 138 248 618 | -3.9% | 15.6% | 1.2 | -12.6% |
| RESPERO MYRTOL | 103 687 | -36.9% | 7.3% | -1 | 58 772 735 | -31.3% | 8.4% | -0.6 | -28.3% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"## [1] "ESPUMISAN (ADULTS)"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"## [1] "ESPUMISAN BABY"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"## [1] "FASTUM"## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"## [1] "LIOTON"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"## [1] "MEZYM"## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS 20000 IU #20"## [1] "MEZYM FORTE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #80"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS 10000 ED #20"## [1] "DEXALGIN"## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"## [1] "MIG 400"## [1] "MIG 400 COATED TABLETS 400 MG #10"## [1] "MIG 400 COATED TABLETS 400 MG #20"## [1] "PROSTAMOL"## [1] "PROSTAMOL UNO CAPS 320 MG #30"## [1] "PROSTAMOL UNO CAPS 320 MG #60"## [1] "PROSTAMOL UNO CAPS 320 MG #90"## [1] "IODOMARIN"## [1] "IODOMARIN 100 TABS 100 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #50"## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"## [1] "RESPERO MYRTOL"## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs